Purchase by Kavuru Vimal of 676371 shares of Acasti Pharma
ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Slightly above 62% of ACST Old's investor base is looking to short. The analysis of current outlook of investing in ACST Old suggests that many traders are alarmed regarding ACST Old's prospects. ACST Old's investing sentiment can be driven by a variety of factors including economic data, ACST Old's earnings reports, geopolitical events, and overall market trends.
ACST |
Filed transaction by Acasti Pharma Inc director. General open market or private purchase of non-derivative or derivative security
Read at macroaxis.com
ACST Old Fundamental Analysis
We analyze ACST Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACST Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACST Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
ACST Old is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
ACST Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ACST Old stock to make a market-neutral strategy. Peer analysis of ACST Old could also be used in its relative valuation, which is a method of valuing ACST Old by comparing valuation metrics with similar companies.
Peers
ACST Old Related Equities
IBIO | Ibio | 10.16 | ||||
AKTX | Akari Therapeutics | 2.17 | ||||
MBRX | Moleculin Biotech | 1.13 | ||||
PULM | Pulmatrix | 0.48 | ||||
BPTH | Bio Path | 1.83 | ||||
OCGN | Ocugen | 2.22 | ||||
ADTX | Aditxt | 5.00 | ||||
TNXP | Tonix Pharmaceuticals | 6.45 | ||||
GOVX | GeoVax Labs | 6.92 | ||||
JAGX | Jaguar Animal | 7.81 | ||||
ABVC | ABVC Biopharma | 14.71 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in ACST Stock
If you are still planning to invest in ACST Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ACST Old's history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |